IP Library Granted Patent US 12,196,652
Granted Patent B2
US 12,196,652 · App. 17/263,800 · Granted Jan 14, 2025

Methods, kits and stain compositions for flow cytometry evaluation of unassociated virus-size particles using multiple fluorogenic dyes

Inventors: Rebecca K. Montange (Louisville, CO); Antje Schickert (Arvada, CO); Jeffrey W. Steaffens (Broomfield, CO); Michael W. Olszowy (Erie, CO)
Assignee: Sartorius Bioanalytical Instruments, Inc.
G01N1/30G01N15/1459G01N2001/302G01N2015/1006G01N2015/1488
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,196,652
App. No.
17/263,800
Granted
Jan 14, 2025
Kind
B2
Abstract

In flow cytometry evaluation for unassociated virus-size particles stained with multiple fluorogenic dyes, the fluid sample is stained with an aqueous diluted dye formulation including multiple fluorogenic dyes. Preparation of the aqueous diluted dye formulation includes first preparatory processing to prepare a concentrated dye formulation with the fluorogenic dyes provided in a dry powder mixture mixed with and dissolved into a first liquid medium comprising DMSO. After the first preparatory processing, aqueous liquid diluent is added to dilute the first liquid medium and while the fluorogenic dyes remain in solution the liquid medium is converted to an aqueous liquid medium, which may include DMSO as a minor molar component but at a significant concentration. The stained fluid sample may include dissolved disaccharide.

Claims (40)

1. A fluorogenic stain composition for fluorescent staining of unassociated virus-size particles with multiple fluorogenic dyes for flow cytometry evaluation for the stained unassociated virus-size particles in a fluid sample, the fluorogenic stain composition comprising:

a plurality of different fluorogenic dyes each having a different fluorescent emission signature and each containing at least one aromatic group susceptible to pi stacking, the plurality of different fluorogenic dyes including at least a first fluorogenic dye with a first fluorescent emission signature and a second fluorogenic dye with a second fluorescent emission signature that is different than the first fluorescent emission signature; and

an aqueous liquid medium in which the plurality of different fluorogenic dyes are dissolved, the aqueous liquid medium comprising a disaccharide dissolved in the aqueous liquid medium.

2. The fluorogenic stain composition of claim 1 , comprising the disaccharide at a concentration of at least 1 weight percent.

3. The fluorogenic stain composition of claim 2 , comprising the disaccharide at a concentration of not greater than 45 weight percent.

4. The fluorogenic stain composition of claim 3 , comprising a weight-to-volume concentration of the first fluorogenic dye and a weight-to-volume concentration of the second fluorogenic dye each in a range of from 1 to 1000 micrograms per milliliter.

5. The fluorogenic stain composition of claim 3 , wherein the disaccharide comprises trehalose.

6. The fluorogenic stain composition of claim 3 , comprising one or more disaccharide materials, wherein the one or more disaccharide materials comprise trehalose, sucrose, lactose, lactulose, melibiose, melibiulose, cellobiose, nigerose, isomaltose, isomaltulose, maltulose, rutinose, β-laminaribiose, or maltose, or combinations thereof.

7. The fluorogenic stain composition of claim 1 , wherein the first fluorogenic dye is for nonspecific nucleic acid staining and the second fluorogenic dye is for nonspecific protein staining.

8. The fluorogenic stain composition of claim 7 , wherein each of the first fluorogenic dye and the second fluorogenic dye is a cyanine dye.

9. A method for flow cytometry evaluation of a fluid sample for unassociated virus-size particles stained with multiple fluorogenic dyes susceptible to pi stacking interactions in aqueous liquid, the method comprising:

preparing a stained fluid sample for flow cytometry evaluation, comprising mixing at least a portion of a fluorogenic stain composition with a sample of biological material to be evaluated by flow cytometry for presence of the unassociated virus-size particles;

after the preparing, subjecting the stained fluid sample to flow cytometry in a flow cytometer to detect and count occurrences of the unassociated virus-size particles stained with both a first fluorogenic dye and a second fluorogenic dye; and

wherein the fluorogenic stain composition comprises:

a plurality of different fluorogenic dyes each having a different fluorescent emission signature and each containing at least one aromatic group susceptible to pi stacking, the plurality of different fluorogenic dyes including at least the first fluorogenic dye with a first fluorescent emission signature and the second fluorogenic dye with a second fluorescent emission signature that is different than the first fluorescent emission signature, and wherein the first fluorogenic dye is for nonspecific nucleic acid staining and the second fluorogenic dye is for nonspecific protein staining; and

an aqueous liquid medium in which the plurality of different fluorogenic dyes are dissolved, the aqueous liquid medium comprising a disaccharide dissolved in the aqueous liquid medium.

10. The method of claim 9 , wherein the fluorogenic stain composition comprises the disaccharide at a concentration in a range of from 1 weight percent to 45 weight percent.

11. The method of claim 10 , wherein the first fluorogenic dye is for nonspecific nucleic acid staining and the second fluorogenic dye is for nonspecific protein staining.

12. The method of claim 11 , wherein the unassociated virus-size particles have a size in a range of from 10 nanometers to one micron.

13. The method of claim 12 , wherein the flow cytometry comprises:

hydrodynamically focusing a flow of the stained fluid sample with a sheath fluid; and

flowing the hydrodynamically focused stained fluid sample through a flow cell in which the flowing hydrodynamically focused stained fluid sample is subjected to excitation radiation to stimulate a fluorescent emission response from each of the first fluorogenic dye and the second fluorogenic dye on the unassociated virus-size particles stained with both the first fluorogenic dye and the second fluorogenic dye; and

separately detecting for each of the first fluorescent emission signature and the second fluorescent emission signature and time correlating detection of the first fluorescent emission signature and detection of the second fluorescent emission signature to determine a detection event indicative of an occurrence of a said unassociated virus-size particle stained with both the first fluorogenic dye and the second fluorogenic dye.

14. A method for flow cytometry evaluation of a stained fluid sample for unassociated virus-size particles stained with multiple fluorogenic dyes susceptible to pi stacking interactions in aqueous liquid, the method comprising:

subjecting the stained fluid sample to flow cytometry evaluation for the unassociated virus-size particles, wherein the stained fluid sample comprises:

biological material to be evaluated by flow cytometry for presence of the unassociated virus-size particles;

a plurality of different fluorogenic dyes each having a different fluorescent emission signature and each containing at least one aromatic group susceptible to pi stacking, the plurality of different fluorogenic dyes including at least a first fluorogenic dye with the first fluorescent emission signature and a second fluorogenic dye with a second fluorescent emission signature that is different than the first fluorescent emission signature; and

an aqueous liquid in which the biological material and fluorogenic dyes are dispersed;

wherein the flow cytometry evaluation comprises subjecting the stained fluid sample to flow cytometry in a flow cytometer to detect and count occurrences of the unassociated virus-size particles stained with both the first fluorogenic dye and the second fluorogenic dye; and

wherein the aqueous liquid of the stained fluid sample comprises dissolved disaccharide.

15. The method of claim 14 , wherein the stained fluid sample comprises a concentration of the dissolved disaccharide of at least 0.5 weight percent.

16. The method of claim 15 , wherein the stained fluid sample has a concentration of dissolved disaccharide of not greater than 15 weight percent.

17. The method of claim 16 , wherein the wherein the first fluorogenic dye is for nonspecific nucleic acid staining and the second fluorogenic dye is for nonspecific protein staining.

18. The method of claim 14 , wherein the unassociated virus-size particles have a size in a range of from 10 nanometers to one micron.

19. The method of claim 18 , wherein the flow cytometry comprises:

hydrodynamically focusing a flow of the stained fluid sample with a sheath fluid; and

flowing the hydrodynamically focused stained fluid sample through a flow cell in which the flowing hydrodynamically focused stained fluid sample is subjected to excitation radiation to stimulate a fluorescent emission response from each of the first fluorogenic dye and the second fluorogenic dye on the unassociated virus-size particles stained with both the first fluorogenic dye and the second fluorogenic dye; and

detecting for both the first fluorescent emission signature and the second fluorescent emission signature; and

wherein, the flowing comprises maintaining a flow rate of the hydrodynamically focused stained fluid sample through the flow cell in a range of from 300 nanoliters per minute to 6000 nanoliters per minute.

20. The method of claim 19 , wherein the flow cytometry comprises separately detecting for each of the first fluorescent emission signature and the second fluorescent emission signature and time correlating detection of the first fluorescent emission signature and detection of the second fluorescent emission signature to determine a detection event indicative of an occurrence of a said unassociated virus-size particle stained with both the first fluorogenic dye and the second fluorogenic dye.

Assignments (8)
MERGER Recorded Mar 16, 2022
From: ESSEN INSTRUMENTS, INC. D/B/A ESSEN BIOSCIENCE, INC.
To: SARTORIUS BIOANALYTICAL INSTRUMENTS, INC.
Reel/Frame 059276/0864 →
MERGER Recorded Mar 16, 2022
From: ESSEN INSTRUMENTS, INC. D/B/A ESSEN BIOSCIENCE, INC.
To: SARTORIUS BIOANALYTICAL INSTRUMENTS, INC.
Reel/Frame 059277/0312 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE NAME OF THE RECEIVING PARTY PREVIOUSLY RECORDED AT REEL: 056520 FRAME: 0820. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 17, 2021
From: MONTANGE, REBECCA K.
To: SARTORIUS STEDIM NORTH AMERICA INC.
Reel/Frame 056613/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: SARTORIUS STEDIM NORTH AMERICA INC.
To: ESSEN INSTRUMENTS, INC. D/B/A ESSEN BIOSCIENCE, INC.
Reel/Frame 056466/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: SCHICKERT, ANTJE
To: SARTORIUS STEDIM NORTH AMERICA INC.
Reel/Frame 056466/0653 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: MONTANGE, REBECCA K.
To: SARTORIOUS STEDIM NORTH AMERICA INC.
Reel/Frame 056520/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: OLSZOWY, MICHAEL W.
To: SARTORIUS STEDIM NORTH AMERICA INC.
Reel/Frame 056466/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2021
From: STEAFFENS, JEFFREY W.
To: SARTORIUS STEDIM NORTH AMERICA INC.
Reel/Frame 056466/0739 →
Continuity (2)
Provisional Application 62713377 · Aug 1, 2018
Related Publication 20210181073A1 · Jun 17, 2021
References Cited (177)
US 4857451A · Schwartz · 1989 [cited by applicant]
US 5040890A · North, Jr. · 1991 [cited by applicant]
US 5245318A · Tohge et al. · 1993 [cited by applicant]
US 5306467A · Douglas-Hamilton et al. · 1994 [cited by applicant]
US 5321130A · Yue et al. · 1994 [cited by applicant]
US 5351118A · Spinell · 1994 [cited by applicant]
US 5374398A · Isami et al. · 1994 [cited by applicant]
US 5395588A · North, Jr. et al. · 1995 [cited by applicant]
US 5410030A · Yue et al. · 1995 [cited by applicant]
US 5483469A · Van den Engh et al. · 1996 [cited by applicant]
US 5602039A · Van den Engh · 1997 [cited by applicant]
US 5616502A · Haugland et al. · 1997 [cited by applicant]
US 5690895A · Matsumoto et al. · 1997 [cited by applicant]
US 5736105A · Astle · 1998 [cited by applicant]
US 5895764A · Sklar et al. · 1999 [cited by applicant]
US 6110427A · Uffenheimer · 2000 [cited by applicant]
US 6183697B1 · Tanaka et al. · 2001 [cited by applicant]
US 6248590B1 · Malachowski · 2001 [cited by applicant]
US 6256096B1 · Johnson · 2001 [cited by applicant]
US 6432630B1 · Blankenstein · 2002 [cited by applicant]
US 6550324B1 · Mayer et al. · 2003 [cited by applicant]
US 6589792B1 · Malachowski · 2003 [cited by applicant]
US 6592822B1 · Chandler · 2003 [cited by applicant]
US 6597438B1 · Cabuz et al. · 2003 [cited by applicant]
US 6664047B1 · Haugland et al. · 2003 [cited by applicant]
US 6813944B2 · Mayer et al. · 2004 [cited by applicant]
US 6878556B2 · Sklar et al. · 2005 [cited by applicant]
US 6880414B2 · Norton · 2005 [cited by applicant]
US 6890487B1 · Sklar et al. · 2005 [cited by applicant]
US 7016022B2 · Fritz et al. · 2006 [cited by applicant]
US 7061595B2 · Cabuz et al. · 2006 [cited by applicant]
US 7069191B1 · Moore · 2006 [cited by applicant]
US 7277166B2 · Padmanabhan et al. · 2007 [cited by applicant]
US 7307721B2 · King · 2007 [cited by applicant]
US 7318336B2 · Roth et al. · 2008 [cited by applicant]
US 7355696B2 · Mueth et al. · 2008 [cited by applicant]
US 7368084B2 · Sklar et al. · 2008 [cited by applicant]
US 7420659B1 · Cabuz et al. · 2008 [cited by applicant]
US 7452725B2 · Leary et al. · 2008 [cited by applicant]
US 7471394B2 · Padmanabhan et al. · 2008 [cited by applicant]
US 7485153B2 · Padmanabhan et al. · 2009 [cited by applicant]
US 7553453B2 · Gu et al. · 2009 [cited by applicant]
US 7671987B2 · Padmanabhan et al. · 2010 [cited by applicant]
US 7688427B2 · Cox et al. · 2010 [cited by applicant]
US 7691636B2 · Frazier et al. · 2010 [cited by applicant]
US 7754421B2 · Transfiguracion et al. · 2010 [cited by applicant]
US 7758811B2 · Durack et al. · 2010 [cited by applicant]
US 7776268B2 · Rich · 2010 [cited by applicant]
US 7780916B2 · Bair et al. · 2010 [cited by applicant]
US 7817276B2 · Kiesel et al. · 2010 [cited by applicant]
US 7978329B2 · Padmanabhan et al. · 2011 [cited by applicant]
US 7981661B2 · Rich · 2011 [cited by applicant]
US 8017402B2 · Rich · 2011 [cited by applicant]
US 8071051B2 · Padmanabhan et al. · 2011 [cited by applicant]
US 8134705B2 · Kaduchak et al. · 2012 [cited by applicant]
US 8182767B2 · Padmanabhan et al. · 2012 [cited by applicant]
US 8187888B2 · Rich · 2012 [cited by applicant]
US 8202733B1 · Javadi · 2012 [cited by applicant]
US 8262990B2 · Bair et al. · 2012 [cited by applicant]
US 8263955B2 · Kiesel et al. · 2012 [cited by applicant]
US 8273294B2 · Padmanabhan et al. · 2012 [cited by applicant]
US 8283177B2 · Ball et al. · 2012 [cited by applicant]
US 8482731B2 · Muraki · 2013 [cited by applicant]
US 9546936B2 · Rowlen et al. · 2017 [cited by applicant]
US 9816912B2 · Artinger et al. · 2017 [cited by applicant]
US 9880085B2 · Wilson et al. · 2018 [cited by applicant]
US 9903803B2 · Smolak et al. · 2018 [cited by applicant]
US 9927346B2 · Wilson et al. · 2018 [cited by applicant]
US 10031061B2 · Rowlen et al. · 2018 [cited by applicant]
US 10041103B2 · Bellinzoni et al. · 2018 [cited by applicant]
US 10101262B2 · Artinger · 2018 [cited by examiner]
US 10161850B2 · Artinger · 2018 [cited by examiner]
US 10184878B2 · Smolak et al. · 2019 [cited by applicant]
US 10408734B2 · Artinger et al. · 2019 [cited by applicant]
US 10520420B2 · Smolak et al. · 2019 [cited by applicant]
US 10545084B2 · Artinger · 2020 [cited by examiner]
US 10585030B2 · Artinger et al. · 2020 [cited by applicant]
US 10705007B2 · Rowlen et al. · 2020 [cited by applicant]
US 10739246B2 · Artinger et al. · 2020 [cited by applicant]
US 11137337B2 · Gates et al. · 2021 [cited by applicant]
US 11709116B2 · Montange · 2023 [cited by examiner]
US 20030235919A1 · Chandler · 2003 [cited by applicant]
US 20050105077A1 · Padmanabhan et al. · 2005 [cited by applicant]
US 20060038989A1 · Domack et al. · 2006 [cited by applicant]
US 20060134002A1 · Lin · 2006 [cited by applicant]
US 20060163119A1 · Hirano et al. · 2006 [cited by applicant]
US 20060195268A1 · Vega · 2006 [cited by applicant]
US 20060259253A1 · Ellison et al. · 2006 [cited by applicant]
US 20080021674A1 · Puskas · 2008 [cited by applicant]
US 20080100840A1 · Oma et al. · 2008 [cited by applicant]
US 20080152542A1 · Ball et al. · 2008 [cited by applicant]
US 20080252884A1 · Carr · 2008 [cited by applicant]
US 20090023132A1 · Champseix · 2009 [cited by applicant]
US 20090029870A1 · Ward et al. · 2009 [cited by applicant]
US 20090104075A1 · Rich · 2009 [cited by applicant]
US 20090105963A1 · Laursen et al. · 2009 [cited by applicant]
US 20100261153A1 · Scholl et al. · 2010 [cited by applicant]
US 20100284016A1 · Teitell et al. · 2010 [cited by applicant]
US 20100319469A1 · Rich · 2010 [cited by applicant]
US 20110024615A1 · Tanner et al. · 2011 [cited by applicant]
US 20110089328A1 · Li · 2011 [cited by applicant]
US 20120077260A1 · Sharon et al. · 2012 [cited by applicant]
US 20120140205A1 · Kaduchak et al. · 2012 [cited by applicant]
US 20130050782A1 · Heng et al. · 2013 [cited by applicant]
US 20130080082A1 · Howes et al. · 2013 [cited by applicant]
US 20130137135A1 · Tai et al. · 2013 [cited by applicant]
US 20130171683A1 · Durack et al. · 2013 [cited by applicant]
US 20130252237A1 · Wagner · 2013 [cited by applicant]
US 20130327957A1 · Ayliffe · 2013 [cited by applicant]
US 20130338968A1 · Hanashi et al. · 2013 [cited by applicant]
US 20150132766A1 · Yasuda et al. · 2015 [cited by applicant]
US 20160273058A1 · Akashika et al. · 2016 [cited by applicant]
US 20170023570A1 · Reyes · 2017 [cited by applicant]
US 20220268773A1 · Shives · 2022 [cited by examiner]
CA 2796489A1 · 2014 [cited by applicant]
EP 0822404A2 · 1998 [cited by applicant]
EP 1176412A2 · 2002 [cited by applicant]
EP 2652511B1 · 2017 [cited by applicant]
KR 20130128348A · 2013 [cited by applicant]
WO 9306482A1 · 1993 [cited by applicant]
WO 9636882A1 · 1996 [cited by applicant]
WO 2005059178A1 · 2005 [cited by applicant]
WO 2007103969A2 · 2007 [cited by applicant]
WO 2008010120A2 · 2008 [cited by applicant]
WO 2009093017A1 · 2009 [cited by applicant]
WO 2010132053A1 · 2010 [cited by applicant]
WO 2013147114A1 · 2013 [cited by applicant]
WO 2014062719A2 · 2014 [cited by applicant]
WO 2014210370A1 · 2014 [cited by applicant]
WO 2015187700A2 · 2015 [cited by applicant]
WO 2015187783A1 · 2015 [cited by applicant]
WO 2016048872A1 · 2016 [cited by applicant]
WO 2016154283A1 · 2016 [cited by applicant]
WO 2016154286A1 · 2016 [cited by applicant]
WO 2020028639A1 · 2020 [cited by applicant]
WO 2020197644A1 · 2020 [cited by applicant]
U.S. Appl. No. 16/781,382, entitled, “Evaluating Biological Material for Unassociated Virus-Size Particles”. [cited by applicant]
U.S. Appl. No. 17/263,800, entitled, “Methods, Kits and Stain Compositions for Flow Cytometry Evaluation of Unassociated Virus-Size Particles Using Multiple Fluorogenic Dyes”. [cited by applicant]
U.S. Appl. No. 17/441,177, entitled, “Flow Cytometry Evaluation for Unassociated Non-Enveloped Viral Particles”. [cited by applicant]
U.S. Appl. No. 16/781,782, entitled, “Liquid Flourescent Dye Concentrate for Flow Cytometry Evaluation of Virus-Size Particles and Related Products and Methods”. [cited by applicant]
Virus Counter(R), Hardware Model: 3100, Software Version 3.0, Operation Manual, Sartorius; Rev B, Mar. 2018. [cited by applicant]
Rossi et al.; “Evaluation of ViroCyt Virus Counter for Rapid Filovirus Quantification”; Viruses; Feb. 20, 2015; 7; pp. 857-872. [cited by applicant]
Stoffel et al.; “Design and Characterization of a Compact Dual Channel Virus Counter”; Cytometry Part A, 65A, Wiley-Liss, Inc. (2005), pp. 140-147. [cited by applicant]
Wikipedia; “Virus Quantification”; http://en.wikipedia.org/wiki/Virus_quantification; 8 pgs. [cited by applicant]
Automation.com; “Honeywell Introduces High-Performance, Liquid Nano-Flow Sensor”; Jul. 30, 2004; 5 pgs. [cited by applicant]
Hercher et al.; “Detection and Discrimination of Individual Viruses by Flow Cytometry”; Journal of Histochemistry & Cytochemistry; Jan. 1, 1979; pp. 350-352. [cited by applicant]
Molecular Probes, “Electrophoretic Mobility-Shift Assay (EMSA) Kit (E33075)”, Product Information MP33075, 2007, 4 pages. [cited by applicant]
Gates, Tyler et al., “Real Time Quantification of Lentivirus Particles Using Antibody-Based Detection on the Virus Counter® 3100 Platform”, 2018, Sartorius Stedim Biotech, 4 pages. [cited by applicant]
Gates, Tyler et al., “Rapid, Real Time Quantification of Lentivirus Particles Using Antibody-Based Detection on the Virus Counter® 3100 Platform”, Application Note, 2018, Sartorius, 4 pages. [cited by applicant]
Decherchi et al, “Dual staining assessment of Schwann cell viability within whole peripheral nerves using calcein-AM and ethidium homodimer”, Journal of Neuroscience Methods., vol. 71, No. 2, 1997, pp. 205-213. [cited by applicant]
Natunen, Katariina et al., “Nile Red staining of phytoplankton neutral lipids: species-specific fluorescence kinetics in various solvents”, J Appl Phycol, 2015, vol. 27, pp. 1161-1169 (published online Sep. 17, 2014). [cited by applicant]
Stacking (chemistry), Wikipedia, 10 pages, accessed Apr. 28, 2018. [cited by applicant]
S6653, SYPRO® Red protein gel stain, Safety Data Sheet, ThermoFisher Scientific, 2018, 9 pages. [cited by applicant]
Wong, Amy G. et al., “The dye SYPRO orange binds to amylin amyloid fibrils but not pre-fibrillar intermediates”, Protein Science, 2016, vol. 25, pp. 1834-1840. [cited by applicant]
P3584, POPO™-3 iodide (534/570) *1 mM solution in DMF*, Safety Data Sheet, Life Technologies, 2013, 7 pages. [cited by applicant]
Zhegalova, Natalia G. et al., “Minimization of self-quenching fluorescence on dyes conjugated to biomolecules with multiple labeling sites via asymmetrically charged NIR fluorophores”, Contrast Media Mol Imaging, 2014, … [cited by applicant]
SYPRO® Orange and SYPRO® Red Protein Gel Stains, Product Information, 2003, Molecular Probes, 5 pages. [cited by applicant]
Dimeric Cyanine Nucleic Acid Stains, Product Information, 2000, Molecular Probes, 4 pages. [cited by applicant]
Guryev, Oleg et al., “Control of the Fluorescence of Dye-Antibody Conjugates by (2-Hydroxypropyl)-ß-cyclodextrin in Fluorescence Microscopy and Flow Cytometry”, Analytical Chemistry, 2011, vol. 83, pp. 7109-7114. [cited by applicant]
Steinberg, Thomas H., Chapter 31, Protein Gel Staining Methods: An Introduction and Overview, Methods in Enzymology, vol. 463, 2009, pp. 541-563. [cited by applicant]
Hawe, Andrea et al., “Extrinsic Fluorescent Dyes as Tools for Protein Characterization”, Pharmaceutical Research, vol. 25, No. 7, 2008, pp. 1487-1499. [cited by applicant]
Handbook of Flourescent Probes and Research Products, 2002, Molecular Probes, Table of Contents (2 pages), and pp. 1-6 (Introduction), 269-287 (Section 8.1, Nucleic Acid Stains), 355-377 (Section 9.1, Introduction to Pr… [cited by applicant]
Virus Counter(R), 3100 Reagent Kit, Part No. VIR-92333, Sartorius, 2018; Reference Doc: 3987, Effective Date Dec. 14, 2018, 1 page. [cited by applicant]
Matthiesen, Steen H et al., “Fast and Non-Toxic In Situ Hybridization without Blocking of Repetive Sequences”, PLoS One, Jul. 2012, vol. 7, Issue 7, e40675, pp. 1-8. [cited by applicant]
Suomalainen, Maarit et al., “Uncoating of non-enveloped viruses” SciVerse Science Direct, CurrentOpinion in Virology, www.sciencedirect.com, 2013, vol. 3, pp. 27-33. [cited by applicant]
Phelps, Donald K. et al., “Theoretical studies of viral capsid proteins”, Current Opinion in Structural Biology, 2000, Department of Medicinal Chemistry, Purdue University, vol. 10, pp. 170-173. [cited by applicant]
Lin, Jun et al., “Structure of the Fab-Labeled ‘Breathing’ State of Native Poliovirus”, Journal of Virology, downloaded from http://jvi.asm.og on Jan. 26, 2017; Mar. 7, 2012, vol. 86, No. 10, pp. 5959-5962. [cited by applicant]
Wang, Lintao et al., “Detecting structural changes in viral capsids by hydrogen exchange and mass spectometry”, Protein Science, 2001, vol. 10, pp. 1234-1243. [cited by applicant]
Bremner, K. Helen et al., Adenovirus Transport via Direct Interaction of Cytoplasmic Dynein with the Viral Capsid Hexon Subunit, Cell Host & Microbe Article, Dec. 17, 2009, vol. 6, pp. 523-535. [cited by applicant]
Varga, Mikael J. et al., “Antibodies with Specificities against a Dispase-Produced 15-Kilodalton Hexon Fragment Neutralize Adenovirus Type 2 Infectivity” Journal of Virology, vol. 64, No. 9, Sep. 1990, pp. 4217-4225. [cited by applicant]
Scherer, Julian et al., “Adenovirus Recruits Dynein by an Evolutionary Novel Mechanism Involving Direct Binding to pH-Primed Hexon”, www.dmpi.com/journal/viruses, 2011, doi: 10.3390/v3081417, vol. 3, pp. 1417-1431. [cited by applicant]
Salganik, Maxim et al., “Evidence for pH-Dependent Protease Activity in the Adeno-Associated Virus Capsid”, Journal of Virology, downloaded from http://jvi.asm.org on Jul. 3, 2018; Nov. 2012, vol. 86, No. 21, pp. 11877-… [cited by applicant]
Moraes, Adolfo H. et al., “Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein”, Journal of Virology, downloaded from http://jvi.asm.org on Aug. 24, 2018; Feb. 2016, vol. 90, No. 4… [cited by applicant]
Haslwanter, Denise et al., “A novel mechanism of antibody-mediated enhancement of flavivirus infection”, PLOS Pathogens, https://doi.org/10.1371/journal.ppat.1006643, Sep. 15, 2017, pp. 1-27. [cited by applicant]
Brown, M.R., et al. “Flow cymetric quantification of viruses in activated sludge”, Water Research, Elsevier, Amsterdam, NL, vol. 68, Oct. 8, 2014, pp. 414-422. [cited by applicant]
Safety Data Sheet Buffer Solution pH4, Carolina Biological Supply Company, Oct. 29, 2015, URL:https://www.lewisu.edu/academics/biology/pdf/pH%20Bufter“/”204.pdt [retrieved on May 15, 2020], 4 pages. [cited by applicant]
El-Hamalawi A-R A et al. “The Fluorometric Determination of Nucleic Acids in Pea Seeds by Use of Ethidium Bromide Complexes”, Analytical Biochemistry, Academic Press, vol. 67, No. 2, Aug. 1, 1975, pp. 384-391. [cited by applicant]
Cited By (1)
US 12,339,283